Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab.
Umeda M, Kojima K, Michitsuji T, Tsuji Y, Shimizu T, Fukui S, Sumiyoshi R, Koga T, Kawashiri SY, Naoki I, Iagawa T, Tamai M, Origuchi T, Furuyama M, Tsuboi M, Matsuoka N, Okada A, Aramaki T, Kawakami A.
Umeda M, et al. Among authors: tsuji y.
Mod Rheumatol. 2024 May 4:roae038. doi: 10.1093/mr/roae038. Online ahead of print.
Mod Rheumatol. 2024.
PMID: 38756072
No abstract available.